Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche


Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate.

The Swiss pharmaceutical giant said Wednesday that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market.

Roche shares jumped in early deals and were trading 5.87% higher as of 11:17 a.m. London time.

Shares of Wegovy-maker Novo Nordisk fell 3.77%, while Zepbound producer Eli Lilly was around 2.7% lower in premarket trading.

Shares of Danish biotech company Zealand Pharma, which is also developing its own obesity treatment, were also down more than 5.6%.

Roche said its experimental once-daily pill CT-996 resulted in a placebo-adjusted average weight loss of 6.1% within four weeks in obese patients without Type 2 diabetes in a Phase I trial.

“We are pleased to see the clinically meaningful weight loss in people treated with our oral GLP-1 therapy CT-996, which could eventually help patients address both chronic weight management and glycemic control indications,” Roche’s Chief Medical Officer Levi Garraway said in the Wednesday statement.

The results come as competition mounts in the fast-growing weight loss drug sector, with Roche’s oral pill likely to provide an appealing alternative for patients who dislike injections.

Roche completed its acquisition of anti-obesity drug developer Carmot Therapeutics in January, and in May the firm released promising early-stage data for another one of its weight loss drug candidates, CT-388.

However, Roche Pharmaceuticals CEO Teresa Graham told CNBC in December that it may be several years before the oral obesity treatments are widely available.



Source

Massive fire breaks out at Chevron oil refinery in California
World

Massive fire breaks out at Chevron oil refinery in California

An aerial view of Chevron crews attempting to extinguish a large fire and explosion that occurred at Chevron Refinery in El Segundo Thursday, Oct. 2, 2025. Allen J. Schaben | Los Angeles Times | Getty Images A huge fire broke out on Thursday night at a Chevron oil refinery in California, one of the largest […]

Read More
The AI trade could rapidly unravel – and one hedge fund is preparing for the fallout
World

The AI trade could rapidly unravel – and one hedge fund is preparing for the fallout

The AI boom is turbo-charging technology stocks, pushing the S & P 500 , the Nasdaq and Dow Jones to fresh record highs. But Karim Moussalem, chief investment officer of equities at Selwood Asset Management, sees “enormous risks” on the horizon for the AI trade which could rapidly unravel — and he is positioning his […]

Read More
CNBC Daily Open: U.S. stock indexes charge ahead with three record closes
World

CNBC Daily Open: U.S. stock indexes charge ahead with three record closes

The “Charging Bull” statue at Bowling Green in New York’s Financial District. Drew Angerer | Getty Images Investors continue to pile into stocks, undeterred by a government shutdown or shaky jobs data, with all three benchmarks hitting record highs Thursday. With the Senate not meeting yesterday because of Yom Kippur, the U.S. government stayed shut […]

Read More